Abstract submissions for the 2027 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting are due December 4, 2026 at 5:00 p.m. ET.

International clinicians and vision-science trainees are welcome to submit abstracts. Please note that a 2027 ARVO membership is required to submit.

The ARVO Annual Meeting will take place May 2–6, 2027 at the San Diego Convention Center in San Diego, California.

Important Dates

• Abstract submission deadline: December 4, 2026 at 5:00 p.m. ET
• Acceptance notices: January 14, 2027
• Early registration deadline: March 10, 2027
• Annual Meeting: May 2–6, 2027

Please review the abstract submission requirements and guidelines before submitting.

Abstract Information & Submission: Abstract Information

Annual Meeting Information: 2027 Annual Meeting

Abstract submissions open October 16, 2026 for the 2027 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting.

The deadline to submit an abstract is December 4, 2026 at 5:00 p.m. ET.

International clinician and vision-science trainees may submit, and 2027 ARVO membership is required to submit an abstract.

The ARVO Annual Meeting will take place May 2–6, 2027 at the San Diego Convention Center in San Diego, California.

Please review the ARVO abstract submission requirements and guidelines before submitting.

Register for ARVO 2027: Register Here

Abstract Information & Submission: Abstract Information

The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting will take place May 2–6, 2027 at the San Diego Convention Center in San Diego, California.

The ARVO Annual Meeting brings together the vision research community for the presentation and discussion of research in ophthalmology and vision science.

Abstract Submissions

Abstract submissions are open from October 16 to December 4, 2026 at 5:00 p.m. ET. International clinician and vision-science trainees may submit, and 2027 ARVO membership is required to submit an abstract.

Important Dates

• Abstract submissions open: October 16, 2026
• Abstract submission deadline: December 4, 2026 at 5:00 p.m. ET
• Acceptance notices: January 14, 2027
• Early registration deadline: March 10, 2027
• Annual Meeting: May 2–6, 2027

Register for the ARVO Annual Meeting: Register here

Video submissions for the 2027 COS Annual Meeting and Exhibition, taking place June 24–27, 2027 in Ottawa, Ontario, are due November 3, 2026 at 3:59 p.m. ET.

Please review the submission guidelines and requirements before submitting.

Submit your abstract or video submission: 2027 COS Annual Meeting and Exhibition – Ottawa

Abstract submissions for the 2027 COS Annual Meeting and Exhibition are due Saturday, October 3, 2026 at 3:59 PM ET.

The 2027 COS Annual Meeting and Exhibition will take place June 24–27, 2027 in Ottawa, Ontario.

Please review the submission guidelines before submitting.

Submit your abstract or video submission: 2027 COS Annual Meeting and Exhibition – Ottawa

Course description

This learning module provides medical students with foundational knowledge and practical resources in ophthalmology. It adheres to the established Canadian curricular objectives, and is designed to teach high-yield information that is sufficient to succeed on the LMCC exam. Through teaching resources and practice questions, learners will review the anatomy of the eye and visual system, the basic eye examination, common ophthalmic presentations, ocular emergencies, ocular pharmacology, and appropriate management and referral.

Learning Objectives

By the end of this module, participants will be able to:

• Describe the anatomy of the eye and the visual system
• Perform a basic eye exam
• Evaluate a patient with acute vision loss
• Evaluate a patient with chronic vision loss
• Evaluate a patient with a red or painful eye
• Evaluate a patient with eye trauma
• Evaluate a patient with an eye movement abnormality, diplopia, or pupillary disorders
• Evaluate ophthalmic problems in children and describe the pathophysiology
• List the most important ocular side effects of systemic drugs
• List the common ocular medications that can have systemic side effects and contraindications to their use
• Describe when it is necessary to urgently refer

Authors

Aidan Pucchio, Kim Papp, Tushar Dave, Farhad Tafreshi, Tyler Herod

Target Audience: Medical Students

Date & Time

September 21, 2026 | 5:00 PM Pacific Time

About the Webinar

Join Dr. Milad Modabber, Cornea, Cataract, and Refractive Surgeon at Herzig Eye Institute in Toronto, for an informative webinar exploring Galaxy and its clinical applications.

Dr. Modabber will share real-world data and insights from his own surgical cases, as well as experience from international users. The webinar will explore clinical outcomes, practical considerations for integrating Galaxy into surgical practice, and key features of the technology.

The program will conclude with an interactive Q&A session.

Learning Objectives

By the end of this webinar, participants will be able to:

• Describe key features and clinical applications of Galaxy.
• Review real-world data collected from Dr. Modabber’s surgical cases.
• Evaluate clinical outcomes.
• Identify practical considerations for integrating Galaxy into surgical practice.

Speaker

Milad Modabber, MD
Cornea, Cataract, and Refractive Surgeon
Herzig Eye Institute, Toronto

Cataract and refractive surgeons and comprehensive ophthalmologists.

COURSE DESCRIPTION

This course provides a comprehensive, clinically focused overview of neurotrophic keratitis. It emphasizes clinical reasoning, understanding the pathophysiology of corneal nerve damage, and identifying prognostic factors. Participants will explore mild to severe presentations, review evidence-based medical and surgical management options, and learn how to prevent long-term complications. By the end of the course, learners will be equipped to manage neurotrophic keratitis across all stages to optimize both visual and anatomical outcomes.

AUTHORS/AFFILIATIONS

• Mai Katbe: Medical Student, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Canada
• Edmond Sandouk, MD: Ophthalmology research fellow, Ophthalmology department, Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada
• Michael Mina, MD: Ophthalmology Resident, Ophthalmology Department, Faculty of Medicine, University of Montreal, Quebec, Canada
• Mona Harissi-Dagher, MD: Ophthalmologist, Ophthalmology department, Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada

DISCLOSURES

• Mai Katbe: None
• Edmond Sandouk, MD: None
• Michael Mina, MD: None 
• Mona Harissi-Dagher, MD: None

TARGET AUDIENCE

Practicing ophthalmologists, ophthalmology residents, medical students.

LEARNING OBJECTIVES

• Understand the pathophysiology of neurotrophic keratitis, including the role of trigeminal nerve dysfunction, epithelial breakdown, tear film instability, and stromal changes.
• Recognize the clinical spectrum of neurotrophic keratitis and its severity stages
• Identify key steps in the acute assessment and management of neurotrophic keratitis.
• Review strategies for chronic management.
• Understand long-term complications and their impact on visual prognosis.

Date/Time
06/11/2026 – 07/11/2026
All Day

Location
Omni King Edward Hotel, Toronto, Ontario, Canada

About the Symposium
Join Canadian retina and glaucoma colleagues and expert guest speakers for an interactive learning experience focused on advances in ophthalmic imaging, including OCT, OCT angiography, wide-field imaging, and artificial intelligence.

Learning Objectives
Explore advances in imaging, apply image findings to clinical decision-making, and gain updated knowledge on evidence-based management of retinal diseases and glaucoma.

Registration is complimentary

Learn More & Register